Partnerships play a crucial role for Sentiss in the commercialization of new products. We leverage partnerships aligning with our business approach in order to effectively distribute, license, and supply products and expand our market presence within the US.

Sentiss is dedicated to the highest quality standards in all its manufacturing processes. With Ophtapharm, our state-of-the-art facility for the US market and other trusted third-party partners, Sentiss adheres to strict quality guidelines and global regulatory requirements. Always focusing on quality, we can ensure that every product, whether produced in-house or externally, meets or exceeds customer expectations.

Ophtapharm, a Sentiss Company, is a leading pharmaceutical manufacturer in Switzerland with 40 years of experience and a team of 250 dedicated employees focused on ophthalmic innovation. Specializing in sterile ophthalmic and otic products, Ophtapharm produces a variety of liquid and semisolid dosage forms, including solutions, suspensions, emulsions, gels, and ointments, all manufactured at their FDA and GMP approved facilities in Hettlingen and Winterthur. Their commitment to cutting-edge technology and rigorous regulatory standards ensures top-tier quality for global customers.